je.st
news
Myriad Genetics (MYGN) Forecasted to Post Q1 2017 Earnings of $0.45 Per Share
2015-11-07 07:41:57| Biotech - Topix.net
Investment analysts at Jefferies Group cut their Q1 2017 earnings per share estimates for shares of Myriad Genetics in a research note issued on Wednesday, according to Zacks Investment Research . Jefferies Group analyst B. Couillard now forecasts that the firm will earn $0.45 per share for the quarter, down from their prior estimate of $0.46.
Tags: post
share
earnings
genetics
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||